循环上皮细胞作为病毒感染和组织起源标志物在患有严重COVID-19的患者中

Valeria Denninghoff1,2, María Del Carmen Garrido-Navas1, María Del Pilar Molina-Vallejo1

  • 1Liquid Biopsy and Cancer Interception Unit, GENYO, Centre for Genomics and Oncological Research (Pfizer/University of Granada/Andalusian Regional Government), Granada, Spain.

PubMed
概括

液体活检 (LB) 在严重的COVID-19患者中检测到更高水平的循环上皮细胞 (CEC). 这种最少的侵入性方法对实时监测传染病进展有希望.